Novo Nordisk said on Tuesday it would cut U.S. list prices for several insulin products by up to 75% next year, joining rival Eli Lilly and Co as political pressure mounts to make these life-sustaining diabetes treatments more affordable.
Biden said in a statement that he was pleased by Novo's move and urged other manufacturers to follow suit.
Novo Nordisk, which had a 43% share of the U.S. and Canada insulin market as of November, also said it would reduce the list price of unbranded insulin products to match lowered prices of respective branded insulin products.month it would cut the list prices for its most commonly prescribed insulin products by 70% in the fourth quarter of this year.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli LillyNovo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following a similar move by Eli Lilly.
Lire la suite »
Following Eli Lilly, drugmaker Novo Nordisk announces cuts to insulin pricesBREAKING: Novo Nordisk says it will lower the U.S. list price of some of its insulin products by up to 75% starting Jan. 1, 2024, following a similar move by Eli Lilly.
Lire la suite »
Novo Nordisk plans to cut insulin prices up to 75%, following Eli LillyNovo will reduce the list price for NovoLog and NovoLog Mix 70/30 by 75%, and cut Novolin and Levemir’s list prices by 65% — but not until 2024.
Lire la suite »
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli LillyNovo Nordisk, along with Sanofi and Eli Lilly, make up most of the U.S. insulin market.
Lire la suite »
Novo Nordisk to lower prices of some insulins, following similar move by LillyNovo Nordisk said that it is lowering the prices of several insulin products by up to 75% starting in 2024. The company’s U.S.-listed shares were up about...
Lire la suite »
Novo Nordisk Will Cut Insulin Cost in U.S. by Up to 75 PercentNovo Nordisk will slash the list price of several of its insulin drugs by as much as 75 percent, the company said Tuesday.
Lire la suite »